BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22223587)

  • 1. Prospective evaluation of the IOTA logistic regression model LR2 for the diagnosis of ovarian cancer.
    Nunes N; Yazbek J; Ambler G; Hoo W; Naftalin J; Jurkovic D
    Ultrasound Obstet Gynecol; 2012 Sep; 40(3):355-9. PubMed ID: 22223587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of IOTA logistic regression models LR1 and LR2 in comparison with subjective pattern recognition for diagnosis of ovarian cancer in an outpatient setting.
    Nunes N; Ambler G; Foo X; Widschwendter M; Jurkovic D
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):829-835. PubMed ID: 28976616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound-based logistic regression model LR2 versus magnetic resonance imaging for discriminating between benign and malignant adnexal masses: a prospective study.
    Shimada K; Matsumoto K; Mimura T; Ishikawa T; Munechika J; Ohgiya Y; Kushima M; Hirose Y; Asami Y; Iitsuka C; Miyamoto S; Onuki M; Tsunoda H; Matsuoka R; Ichizuka K; Sekizawa A
    Int J Clin Oncol; 2018 Jun; 23(3):514-521. PubMed ID: 29236181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses.
    Di Legge A; Testa AC; Ameye L; Van Calster B; Lissoni AA; Leone FP; Savelli L; Franchi D; Czekierdowski A; Trio D; Van Holsbeke C; Ferrazzi E; Scambia G; Timmerman D; Valentin L
    Ultrasound Obstet Gynecol; 2012 Sep; 40(3):345-54. PubMed ID: 22611001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective validation of the IOTA logistic regression models (LR1 and LR2) in comparison to subjective pattern recognition for the diagnosis of ovarian cancer.
    Nunes N; Ambler G; Hoo WL; Naftalin J; Foo X; Widschwendter M; Jurkovic D
    Int J Gynecol Cancer; 2013 Nov; 23(9):1583-9. PubMed ID: 24088790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative diagnostic accuracy of the IOTA SRR and LR2 scoring systems for discriminating between malignant and Benign Adnexal masses by junior physicians in Chinese patients: a retrospective observational study.
    Tian C; Wen SB; Zhao CY; Yan XN; Du JX
    BMC Womens Health; 2023 Nov; 23(1):585. PubMed ID: 37940895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group.
    Timmerman D; Van Calster B; Testa AC; Guerriero S; Fischerova D; Lissoni AA; Van Holsbeke C; Fruscio R; Czekierdowski A; Jurkovic D; Savelli L; Vergote I; Bourne T; Van Huffel S; Valentin L
    Ultrasound Obstet Gynecol; 2010 Aug; 36(2):226-34. PubMed ID: 20455203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.
    Chen H; Qian L; Jiang M; Du Q; Yuan F; Feng W
    Ultrasound Obstet Gynecol; 2019 Dec; 54(6):815-822. PubMed ID: 31152572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of IOTA three-step strategy and logistic regression model LR2 for discriminating between benign and malignant adnexal masses.
    Hidalgo JJ; Llueca A; Zolfaroli I; Veiga N; Ortiz E; Alcázar JL
    Med Ultrason; 2021 May; 23(2):168-175. PubMed ID: 33626112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving diagnostic strategies for ovarian cancer in Filipino women using ultrasound imaging and a multivariate index assay.
    Velayo CL; Reforma KN; Sicam RVG; Diwa MH; Sy ADR; Tantengco OAG
    Cancer Epidemiol; 2022 Dec; 81():102253. PubMed ID: 36179631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra- and interobserver agreement when describing adnexal masses using the International Ovarian Tumor Analysis terms and definitions: a study on three-dimensional ultrasound volumes.
    Sladkevicius P; Valentin L
    Ultrasound Obstet Gynecol; 2013 Mar; 41(3):318-27. PubMed ID: 22915506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.
    Meys EMJ; Jeelof LS; Achten NMJ; Slangen BFM; Lambrechts S; Kruitwagen RFPM; Van Gorp T
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):784-792. PubMed ID: 27514486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the IOTA ADNEX model in preoperative discrimination of adnexal masses in a gynecological oncology center.
    Araujo KG; Jales RM; Pereira PN; Yoshida A; de Angelo Andrade L; Sarian LO; Derchain S
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):778-783. PubMed ID: 27194129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective internal validation of mathematical models to predict malignancy in adnexal masses: results from the international ovarian tumor analysis study.
    Van Holsbeke C; Van Calster B; Testa AC; Domali E; Lu C; Van Huffel S; Valentin L; Timmerman D
    Clin Cancer Res; 2009 Jan; 15(2):684-91. PubMed ID: 19147775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis.
    Kaijser J; Sayasneh A; Van Hoorde K; Ghaem-Maghami S; Bourne T; Timmerman D; Van Calster B
    Hum Reprod Update; 2014; 20(3):449-62. PubMed ID: 24327552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between an ultrasound based prediction model (LR2) and the risk of ovarian malignancy algorithm (ROMA) to assess the risk of malignancy in women with an adnexal mass.
    Kaijser J; Van Gorp T; Van Hoorde K; Van Holsbeke C; Sayasneh A; Vergote I; Bourne T; Timmerman D; Van Calster B
    Gynecol Oncol; 2013 May; 129(2):377-83. PubMed ID: 23360924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validation of diagnostic models to estimate the risk of malignancy in adnexal masses.
    Van Holsbeke C; Van Calster B; Bourne T; Ajossa S; Testa AC; Guerriero S; Fruscio R; Lissoni AA; Czekierdowski A; Savelli L; Van Huffel S; Valentin L; Timmerman D
    Clin Cancer Res; 2012 Feb; 18(3):815-25. PubMed ID: 22114135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of diagnostic efficiency between IOTA LR2 model and doctors
    Zhao B; Fu Y; Wen L; Wang Z; Fu C; Liu M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 47(8):1082-1088. PubMed ID: 36097776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability of IOTA score and ADNEX model in the screening of ovarian malignancy in postmenopausal women.
    Nohuz E; De Simone L; Chêne G
    J Gynecol Obstet Hum Reprod; 2019 Feb; 48(2):103-107. PubMed ID: 29709594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help.
    Valentin L; Ameye L; Savelli L; Fruscio R; Leone FP; Czekierdowski A; Lissoni AA; Fischerova D; Guerriero S; Van Holsbeke C; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2011 Oct; 38(4):456-65. PubMed ID: 21520475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.